Mirae Asset Asia Pacific Health Care Opt Equity Fund
Fund PricesAs of 28/09/2022
|Total Fund Size (USD million)||2.35|
|Net Asset Value per Share (USD)||10.75|
|Daily Change (%)||-0.83%|
AllocationsAs of 31/08/2022
|Fund Weight||Benchmark Weight|
|Allocations are subject to change.|
Source: FactSet, Bloomberg and Mirae Asset Global Investment (Hong Kong) Limited.
All performance numbers are net of fees, NAV to NAV, in USD, and with dividends reinvested.
Fund: The fund inception date was on 29 April 2015 whilst Class I (USD) was launched on 30 April 2015.
The fund performance information is based on Class I which is for professional or qualified investors only. The returns may not be the same as Class A which is for retail investors.
The calendar year return % show by how much the Fund increased or decreased in value during the calendar year being shown. Where no past performance is shown there was insufficient data available in that year to provide performance.
Benchmark: MSCI AC APxJ Health Care 10/40 Index. The benchmark is a gross return index that includes reinvestment of dividends/income.
The Fund is a sub fund of Mirae Asset Global Discovery Fund (the Company) a société d’investissement à capital variable (SICAV) domiciled in Luxembourg structured as an umbrella with a number of sub funds. The value of shares in the Fund may fall as well as rise and investors may not get back the amount originally invested. Past performance is not indicative of future performance. If investing in foreign currencies, the return in the investor’s reference currency may increase or decrease as a result of currency fluctuations. The Company is a Luxembourg registered UCITS, recognized in the UK under section 264 of the Financial Services and Markets Act 2000. Compensation from the UK Financial Services Compensation Scheme will not be available in respect of the Fund. This website has been prepared for marketing, presentation, illustration and discussion purposes only. The views and opinions contained in this website are those of Mirae Asset Global Investments (HK) Ltd., which are subject to change without notice and should not be construed as investment or taxation advice. The provision of this document does not constitute or form part of any offer or recommendation to issue, buy or sell, or any solicitation of any offer to subscribe for or purchase any shares nor shall it or the fact of its distribution form the basis of, or be relied upon in connection with, any contract thereof. Nothing in this document shall be construed as advice.
The data in this website comes partially from third-party sources and as a result the accuracy, completeness or correctness of the information contained in this publication is not guaranteed, and third party data is provided without any warranties of any kind. Neither Mirae Asset Global Investments (UK) Ltd. nor Mirae Asset Global Investments (HK) Ltd. shall have any liability in connection with third party data. This website does not explain all the risks involved in investing in the Fund and therefore you should ensure that you read the Prospectus and the Key Investor Information Documents (“KIID”) which contain further information including the applicable risk warnings. The taxation position affecting UK investors is outlined in the Prospectus. The Prospectus and KIID for the Fund are available free of charge from http:// investments.miraeasset.eu, or from Mirae Asset Global Investments (UK) Ltd., 4th Floor, 4-6 Royal Exchange Buildings, London EC3V 3NL, United Kingdom, telephone +44 (0) 20 7715 9900. This website has been approved for issue in the United Kingdom by Mirae Asset Global Investments (UK) Ltd, a company incorporated in England & Wales with registered number 06044802, and having its registered office at 4th Floor, 4-6 Royal Exchange Buildings, London EC3V 3NL, United Kingdom. Mirae Asset Global Investments (UK) Ltd. is authorised and regulated by the Financial Conduct Authority with firm reference number 467535.